Tapewire

Nasdaq · USD

RLAY

Relay Therapeutics, Inc.

Export transactions ↓
Tapewire entity
4044
SEC CIK
0001812364
Parsed reports
317

Last 12 months

Inside the activity.

0 purchase rows · 37 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202607
Feb 202600
Mar 202601
Apr 202605
May 202601
Jun 202606
Jul 202606
Aug 202604
Sep 202603
Oct 202603

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 28, 2022 Filed Jul 29, 2022 20:42 UTC
Adams BrianChief Legal Officer
SaleCommon Stock 734 $21.27 $15,612.18
Disclosure

SEC source: 0001209191-22-043534 · doc4.xml · nonDerivative · entry 1

Adams Brian · CIK 0001636994 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,842

F1 · shares: Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 2,454 shares of restricted stock units ("RSUs") on July 27, 2022. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.

F2 · balance_after: Includes 45,273 shares underlying RSUs.

Read SEC document
July 25, 2022 Filed Jul 27, 2022 22:57 UTC GrantStock Option (Right to Buy) · Derivative 71,881 $0.00 Strike: $20.46 $0.00
Disclosure

SEC source: 0000899243-22-026903 · doc4.xml · derivative · entry 1

Kathiresan Sekar · CIK 0001864112 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,881

Underlying: Common Stock · 71,881 shares

Expires 2032-07-24

F1 · derivative.exercise_date: The shares underlying this stock option shall vest in thirty-six (36) equal monthly installments after July 25, 2022, subject to the reporting person's continued service with the Issuer through each vesting date.

Read SEC document
July 06, 2022 Filed Jul 8, 2022 20:17 UTC
Bergstrom Donald APresident, R&D
Exercise / conversionStock Option (Right to Buy) · Derivative 8,000 $0.00 Strike: $4.12 $0.00
Disclosure

SEC source: 0001209191-22-041628 · doc4.xml · derivative · entry 3

Bergstrom Donald A · CIK 0001709772 · President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 170,456

Underlying: Common Stock · 8,000 shares

Expires 2028-04-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Twenty-five percent (25%) of the shares underlying this option vested on April 2, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date.

Read SEC document
July 06, 2022 Filed Jul 8, 2022 20:17 UTC
Bergstrom Donald APresident, R&D
SaleCommon Stock 8,000 $20.00 $160,000.00
Disclosure

SEC source: 0001209191-22-041628 · doc4.xml · nonDerivative · entry 2

Bergstrom Donald A · CIK 0001709772 · President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,494

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 7, 2022.

F2 · balance_after: Includes 84,953 shares underlying restricted stock units.

Read SEC document
July 06, 2022 Filed Jul 8, 2022 20:17 UTC
Bergstrom Donald APresident, R&D
Exercise / conversionCommon Stock 8,000 $4.12 $32,960.00
Disclosure

SEC source: 0001209191-22-041628 · doc4.xml · nonDerivative · entry 1

Bergstrom Donald A · CIK 0001709772 · President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,494

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 7, 2022.

F2 · balance_after: Includes 84,953 shares underlying restricted stock units.

Read SEC document
June 30, 2022 Filed Jul 8, 2022 20:22 UTC
Patel SanjivDirector · President and CEO
GrantCommon Stock 814 $14.24 $11,591.36
Disclosure

SEC source: 0001209191-22-041639 · doc4.xml · nonDerivative · entry 1

Patel Sanjiv · CIK 0001816210 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 254,554

F1 · kind: The shares were acquired under the Relay Therapeutics, Inc. 2020 Employee Stock Purchase Plan ("ESPP") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The reporting person is voluntarily reporting this transaction.

F2 · price: In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on June 30, 2022.

Read SEC document
June 27, 2022 Filed Jun 28, 2022 21:59 UTC
Catinazzo ThomasChief Financial Officer
SaleCommon Stock 300 $20.31 $6,093.00
Disclosure

SEC source: 0001209191-22-039659 · doc4.xml · nonDerivative · entry 1

Catinazzo Thomas · CIK 0001818261 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,952

F1 · shares: Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 992 shares of restricted stock units ("RSUs") on June 26, 2022. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.

F2 · balance_after: Includes 47,727 shares underlying RSUs.

Read SEC document
June 27, 2022 Filed Jun 28, 2022 22:03 UTC
Porter AndyChief Administrative Officer
SaleCommon Stock 265 $20.31 $5,382.15
Disclosure

SEC source: 0001209191-22-039662 · doc4.xml · nonDerivative · entry 1

Porter Andy · CIK 0001899340 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,323

F1 · shares: Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 875 shares of restricted stock units ("RSUs") on June 26, 2022. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.

F2 · balance_after: Includes 32,285 shares underlying RSUs.

Read SEC document
June 27, 2022 Filed Jun 28, 2022 21:56 UTC
Adams BrianChief Legal Officer
SaleCommon Stock 300 $20.31 $6,093.00
Disclosure

SEC source: 0001209191-22-039656 · doc4.xml · nonDerivative · entry 1

Adams Brian · CIK 0001636994 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,576

F1 · shares: Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 992 shares of restricted stock units ("RSUs") on June 26, 2022. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.

F2 · balance_after: Includes 47,727 shares underlying RSUs.

Read SEC document
June 27, 2022 Filed Jun 28, 2022 21:53 UTC
Bergstrom Donald APresident, R&D
SaleCommon Stock 999 $20.31 $20,289.69
Disclosure

SEC source: 0001209191-22-039654 · doc4.xml · nonDerivative · entry 3

Bergstrom Donald A · CIK 0001709772 · President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,494

F3 · shares: Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 2,188 shares of RSUs on June 26, 2022. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.

F4 · balance_after: Includes 84,953 shares underlying RSUs.

Read SEC document
June 24, 2022 Filed Jun 28, 2022 21:53 UTC
Bergstrom Donald APresident, R&D
Exercise / conversionStock Option (Right to Buy) · Derivative 8,000 $0.00 Strike: $4.12 $0.00
Disclosure

SEC source: 0001209191-22-039654 · doc4.xml · derivative · entry 4

Bergstrom Donald A · CIK 0001709772 · President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 178,456

Underlying: Common Stock · 8,000 shares

Expires 2028-04-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Twenty-five percent (25%) of the shares underlying this option vested on April 2, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date.

Read SEC document
June 24, 2022 Filed Jun 28, 2022 21:53 UTC
Bergstrom Donald APresident, R&D
SaleCommon Stock 8,000 $20.00 $160,000.00
Disclosure

SEC source: 0001209191-22-039654 · doc4.xml · nonDerivative · entry 2

Bergstrom Donald A · CIK 0001709772 · President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,493

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 7, 2022.

F2 · balance_after: Includes 87,141 shares underlying restricted stock units ("RSUs").

Read SEC document
June 24, 2022 Filed Jun 28, 2022 21:53 UTC
Bergstrom Donald APresident, R&D
Exercise / conversionCommon Stock 8,000 $4.12 $32,960.00
Disclosure

SEC source: 0001209191-22-039654 · doc4.xml · nonDerivative · entry 1

Bergstrom Donald A · CIK 0001709772 · President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,493

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 7, 2022.

F2 · balance_after: Includes 87,141 shares underlying restricted stock units ("RSUs").

Read SEC document
May 27, 2022 Filed May 27, 2022 21:38 UTC
HILL LINDA ADirector
GrantStock Option (Right to Buy) · Derivative 41,597 $0.00 Strike: $17.33 $0.00
Disclosure

SEC source: 0001209191-22-032679 · doc4.xml · derivative · entry 1

HILL LINDA A · CIK 0001130483 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,597

Underlying: Common Stock · 41,597 shares

Expires 2032-05-26

F1 · derivative.exercise_date: This option was granted on May 27, 2022 with respect to 41,597 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date.

Read SEC document
May 27, 2022 Filed May 27, 2022 17:33 UTC
Rubin JamiDirector
GrantStock Option (Right to Buy) · Derivative 41,597 $0.00 Strike: $17.33 $0.00
Disclosure

SEC source: 0001209191-22-032671 · doc4.xml · derivative · entry 1

Rubin Jami · CIK 0001816484 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,597

Underlying: Common Stock · 41,597 shares

Expires 2032-05-26

F1 · derivative.exercise_date: This option was granted on May 27, 2022 with respect to 41,597 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date.

Read SEC document
May 27, 2022 Filed May 27, 2022 21:41 UTC
Murcko MarkDirector
GrantStock Option (Right to Buy) · Derivative 41,597 $0.00 Strike: $17.33 $0.00
Disclosure

SEC source: 0001209191-22-032685 · doc4.xml · derivative · entry 1

Murcko Mark · CIK 0001816130 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,597

Underlying: Common Stock · 41,597 shares

Expires 2032-05-26

F1 · derivative.exercise_date: This option was granted on May 27, 2022 with respect to 41,597 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date.

Read SEC document
May 27, 2022 Filed May 27, 2022 21:39 UTC GrantStock Option (Right to Buy) · Derivative 41,597 $0.00 Strike: $17.33 $0.00
Disclosure

SEC source: 0001209191-22-032682 · doc4.xml · derivative · entry 1

INGRAM DOUGLAS S · CIK 0001190644 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,597

Underlying: Common Stock · 41,597 shares

Expires 2032-05-26

F1 · derivative.exercise_date: This option was granted on May 27, 2022 with respect to 41,597 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date.

Read SEC document
May 27, 2022 Filed May 27, 2022 21:37 UTC GrantStock Option (Right to Buy) · Derivative 41,597 $0.00 Strike: $17.33 $0.00
Disclosure

SEC source: 0001209191-22-032676 · doc4.xml · derivative · entry 1

Borisy Alexis · CIK 0001319446 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,597

Underlying: Common Stock · 41,597 shares

Expires 2032-05-26

F1 · derivative.exercise_date: This option was granted on May 27, 2022 with respect to 41,597 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date.

Read SEC document
May 27, 2022 Filed May 27, 2022 21:35 UTC GrantStock Option (Right to Buy) · Derivative 41,597 $0.00 Strike: $17.33 $0.00
Disclosure

SEC source: 0001209191-22-032674 · doc4.xml · derivative · entry 1

Shawver Laura · CIK 0001551891 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,597

Underlying: Common Stock · 41,597 shares

Expires 2032-05-26

F1 · derivative.exercise_date: This option was granted on May 27, 2022 with respect to 41,597 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date.

Read SEC document
May 02, 2022 Filed May 3, 2022 00:24 UTC
Bergstrom Donald APresident, R&D
Exercise / conversionStock Option (Right to Buy) · Derivative 13,000 $0.00 Strike: $4.12 $0.00
Disclosure

SEC source: 0001209191-22-026535 · doc4.xml · derivative · entry 4

Bergstrom Donald A · CIK 0001709772 · President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 186,456

Underlying: Common Stock · 13,000 shares

Expires 2028-04-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Twenty-five percent (25%) of the shares underlying this option vested on April 2, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date.

Read SEC document
May 02, 2022 Filed May 3, 2022 00:24 UTC
Bergstrom Donald APresident, R&D
SaleCommon Stock 13,000 $24.62 $320,060.00
Disclosure

SEC source: 0001209191-22-026535 · doc4.xml · nonDerivative · entry 3

Bergstrom Donald A · CIK 0001709772 · President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,493

F3 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 7, 2022.

F4 · price: This transaction was executed in multiple trades at prices ranging from $23.09 to $25.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F2 · balance_after: Includes 87,141 shares underlying RSUs.

Read SEC document
May 02, 2022 Filed May 3, 2022 00:24 UTC
Bergstrom Donald APresident, R&D
Exercise / conversionCommon Stock 13,000 $4.12 $53,560.00
Disclosure

SEC source: 0001209191-22-026535 · doc4.xml · nonDerivative · entry 2

Bergstrom Donald A · CIK 0001709772 · President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,493

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 7, 2022.

F2 · balance_after: Includes 87,141 shares underlying RSUs.

Read SEC document
April 28, 2022 Filed May 3, 2022 00:07 UTC
Catinazzo ThomasChief Financial Officer
SaleCommon Stock 725 $25.57 $18,538.25
Disclosure

SEC source: 0001209191-22-026522 · doc4.xml · nonDerivative · entry 1

Catinazzo Thomas · CIK 0001818261 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,252

F1 · shares: Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 2,454 shares of restricted stock units ("RSUs") on April 27, 2022. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.

F2 · balance_after: Includes 48,719 shares underlying RSUs.

Read SEC document
April 28, 2022 Filed May 3, 2022 00:24 UTC
Bergstrom Donald APresident, R&D
SaleCommon Stock 1,811 $25.57 $46,307.27
Disclosure

SEC source: 0001209191-22-026535 · doc4.xml · nonDerivative · entry 1

Bergstrom Donald A · CIK 0001709772 · President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,493

F1 · shares: Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 4,059 shares of restricted stock units ("RSUs") on April 27, 2022. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.

F2 · balance_after: Includes 87,141 shares underlying RSUs.

Read SEC document
April 28, 2022 Filed May 3, 2022 00:13 UTC
Porter AndyChief Administrative Officer
SaleCommon Stock 435 $25.57 $11,122.95
Disclosure

SEC source: 0001209191-22-026526 · doc4.xml · nonDerivative · entry 1

Porter Andy · CIK 0001899340 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,588

F1 · shares: Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 1,510 shares of restricted stock units ("RSUs") on April 27, 2022. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.

F2 · balance_after: Includes 33,160 shares underlying RSUs.

Read SEC document
April 28, 2022 Filed May 3, 2022 00:03 UTC
Adams BrianChief Legal Officer
SaleCommon Stock 708 $25.57 $18,103.56
Disclosure

SEC source: 0001209191-22-026520 · doc4.xml · nonDerivative · entry 1

Adams Brian · CIK 0001636994 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,876

F1 · shares: Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 2,454 shares of restricted stock units ("RSUs") on April 27, 2022. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.

F2 · balance_after: Includes 48,719 shares underlying RSUs.

Read SEC document
April 14, 2022 Filed Apr 15, 2022 01:20 UTC
Patel SanjivDirector · President and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 14,000 $0.00 Strike: $5.04 $0.00
Disclosure

SEC source: 0001209191-22-024487 · doc4.xml · derivative · entry 15

Patel Sanjiv · CIK 0001816210 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 704,604

Underlying: Common Stock · 14,000 shares

Expires 2029-04-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2021.

F7 · derivative.exercise_date: The shares underlying this option shall vest in sixteen (16) equal quarterly installments after April 23, 2019, subject to the reporting person's continued employment through each applicable vesting date.

Read SEC document
April 14, 2022 Filed Apr 15, 2022 01:20 UTC
Patel SanjivDirector · President and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 14,000 $0.00 Strike: $4.12 $0.00
Disclosure

SEC source: 0001209191-22-024487 · doc4.xml · derivative · entry 14

Patel Sanjiv · CIK 0001816210 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,175

Underlying: Common Stock · 14,000 shares

Expires 2028-03-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2021.

F6 · derivative.exercise_date: The shares underlying this option shall vest in sixteen (16) equal quarterly installments after March 23, 2018, subject to the reporting person's continued employment through each applicable vesting date.

Read SEC document
April 14, 2022 Filed Apr 15, 2022 01:20 UTC
Patel SanjivDirector · President and CEO
SaleCommon Stock 14,000 $30.51 $427,140.00
Disclosure

SEC source: 0001209191-22-024487 · doc4.xml · nonDerivative · entry 10

Patel Sanjiv · CIK 0001816210 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 253,740

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2021.

F5 · price: This transaction was executed in multiple trades at prices ranging from $30.00 to $32.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
April 14, 2022 Filed Apr 15, 2022 01:20 UTC
Patel SanjivDirector · President and CEO
Exercise / conversionCommon Stock 14,000 $5.04 $70,560.00
Disclosure

SEC source: 0001209191-22-024487 · doc4.xml · nonDerivative · entry 9

Patel Sanjiv · CIK 0001816210 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 267,740

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2021.

Read SEC document
April 14, 2022 Filed Apr 15, 2022 01:20 UTC
Patel SanjivDirector · President and CEO
SaleCommon Stock 14,000 $30.51 $427,140.00
Disclosure

SEC source: 0001209191-22-024487 · doc4.xml · nonDerivative · entry 8

Patel Sanjiv · CIK 0001816210 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 253,740

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2021.

F5 · price: This transaction was executed in multiple trades at prices ranging from $30.00 to $32.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
April 14, 2022 Filed Apr 15, 2022 01:20 UTC
Patel SanjivDirector · President and CEO
Exercise / conversionCommon Stock 14,000 $4.12 $57,680.00
Disclosure

SEC source: 0001209191-22-024487 · doc4.xml · nonDerivative · entry 7

Patel Sanjiv · CIK 0001816210 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 267,740

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2021.

Read SEC document
April 13, 2022 Filed Apr 15, 2022 01:20 UTC
Patel SanjivDirector · President and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 14,000 $0.00 Strike: $5.04 $0.00
Disclosure

SEC source: 0001209191-22-024487 · doc4.xml · derivative · entry 13

Patel Sanjiv · CIK 0001816210 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 718,604

Underlying: Common Stock · 14,000 shares

Expires 2029-04-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2021.

F7 · derivative.exercise_date: The shares underlying this option shall vest in sixteen (16) equal quarterly installments after April 23, 2019, subject to the reporting person's continued employment through each applicable vesting date.

Read SEC document
April 13, 2022 Filed Apr 15, 2022 01:20 UTC
Patel SanjivDirector · President and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 14,000 $0.00 Strike: $4.12 $0.00
Disclosure

SEC source: 0001209191-22-024487 · doc4.xml · derivative · entry 12

Patel Sanjiv · CIK 0001816210 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,175

Underlying: Common Stock · 14,000 shares

Expires 2028-03-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2021.

F6 · derivative.exercise_date: The shares underlying this option shall vest in sixteen (16) equal quarterly installments after March 23, 2018, subject to the reporting person's continued employment through each applicable vesting date.

Read SEC document
April 13, 2022 Filed Apr 15, 2022 01:20 UTC
Patel SanjivDirector · President and CEO
SaleCommon Stock 14,000 $31.94 $447,160.00
Disclosure

SEC source: 0001209191-22-024487 · doc4.xml · nonDerivative · entry 6

Patel Sanjiv · CIK 0001816210 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 253,740

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2021.

F4 · price: This transaction was executed in multiple trades at prices ranging from $31.43 to $32.98. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
April 13, 2022 Filed Apr 15, 2022 01:20 UTC
Patel SanjivDirector · President and CEO
Exercise / conversionCommon Stock 14,000 $5.04 $70,560.00
Disclosure

SEC source: 0001209191-22-024487 · doc4.xml · nonDerivative · entry 5

Patel Sanjiv · CIK 0001816210 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 267,740

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2021.

Read SEC document
April 13, 2022 Filed Apr 15, 2022 01:20 UTC
Patel SanjivDirector · President and CEO
SaleCommon Stock 14,000 $31.96 $447,440.00
Disclosure

SEC source: 0001209191-22-024487 · doc4.xml · nonDerivative · entry 4

Patel Sanjiv · CIK 0001816210 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 253,740

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2021.

F3 · price: This transaction was executed in multiple trades at prices ranging from $31.48 to $32.98. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
April 13, 2022 Filed Apr 15, 2022 01:20 UTC
Patel SanjivDirector · President and CEO
Exercise / conversionCommon Stock 14,000 $4.12 $57,680.00
Disclosure

SEC source: 0001209191-22-024487 · doc4.xml · nonDerivative · entry 3

Patel Sanjiv · CIK 0001816210 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 267,740

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2021.

Read SEC document
April 12, 2022 Filed Apr 15, 2022 01:20 UTC
Patel SanjivDirector · President and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 28,000 $0.00 Strike: $4.12 $0.00
Disclosure

SEC source: 0001209191-22-024487 · doc4.xml · derivative · entry 11

Patel Sanjiv · CIK 0001816210 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 144,175

Underlying: Common Stock · 28,000 shares

Expires 2028-03-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2021.

F6 · derivative.exercise_date: The shares underlying this option shall vest in sixteen (16) equal quarterly installments after March 23, 2018, subject to the reporting person's continued employment through each applicable vesting date.

Read SEC document
April 12, 2022 Filed Apr 15, 2022 01:20 UTC
Patel SanjivDirector · President and CEO
SaleCommon Stock 28,000 $31.80 $890,400.00
Disclosure

SEC source: 0001209191-22-024487 · doc4.xml · nonDerivative · entry 2

Patel Sanjiv · CIK 0001816210 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 253,740

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2021.

F2 · price: This transaction was executed in multiple trades at prices ranging from $30.89 to $32.58. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
April 12, 2022 Filed Apr 15, 2022 01:20 UTC
Patel SanjivDirector · President and CEO
Exercise / conversionCommon Stock 28,000 $4.12 $115,360.00
Disclosure

SEC source: 0001209191-22-024487 · doc4.xml · nonDerivative · entry 1

Patel Sanjiv · CIK 0001816210 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 281,740

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2021.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 21:32 UTC
Bergstrom Donald APresident, R&D
Exercise / conversionStock Option (Right to Buy) · Derivative 18,000 $0.00 Strike: $4.12 $0.00
Disclosure

SEC source: 0001209191-22-023203 · doc4.xml · derivative · entry 3

Bergstrom Donald A · CIK 0001709772 · President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 199,456

Underlying: Common Stock · 18,000 shares

Expires 2028-04-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 7, 2022.

F4 · derivative.exercise_date: Twenty-five percent (25%) of the shares underlying this option vested on April 2, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 21:32 UTC
Bergstrom Donald APresident, R&D
SaleCommon Stock 18,000 $30.32 $545,760.00
Disclosure

SEC source: 0001209191-22-023203 · doc4.xml · nonDerivative · entry 2

Bergstrom Donald A · CIK 0001709772 · President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,304

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 7, 2022.

F3 · price: This transaction was executed in multiple trades at prices ranging from $29.91 to $30.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F2 · balance_after: Includes 91,200 shares underlying restricted stock units.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 21:32 UTC
Bergstrom Donald APresident, R&D
Exercise / conversionCommon Stock 18,000 $4.12 $74,160.00
Disclosure

SEC source: 0001209191-22-023203 · doc4.xml · nonDerivative · entry 1

Bergstrom Donald A · CIK 0001709772 · President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,304

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 7, 2022.

F2 · balance_after: Includes 91,200 shares underlying restricted stock units.

Read SEC document
March 29, 2022 Filed Mar 31, 2022 21:45 UTC
Catinazzo ThomasChief Financial Officer
SaleCommon Stock 282 $29.87 $8,423.34
Disclosure

SEC source: 0001209191-22-021828 · doc4.xml · nonDerivative · entry 1

Catinazzo Thomas · CIK 0001818261 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,977

F1 · shares: Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 992 shares of restricted stock units ("RSUs") on March 26, 2022. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.

F2 · balance_after: Includes 51,173 shares underlying RSUs.

Read SEC document
March 29, 2022 Filed Mar 31, 2022 21:49 UTC
Porter AndyChief Administrative Officer
SaleCommon Stock 294 $29.87 $8,781.78
Disclosure

SEC source: 0001209191-22-021832 · doc4.xml · nonDerivative · entry 1

Porter Andy · CIK 0001899340 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,023

F1 · shares: Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 875 shares of restricted stock units ("RSUs") on March 26, 2022. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.

F2 · balance_after: Includes 34,670 shares underlying RSUs.

Read SEC document
March 29, 2022 Filed Mar 31, 2022 21:37 UTC
Adams BrianChief Legal Officer
SaleCommon Stock 333 $29.87 $9,946.71
Disclosure

SEC source: 0001209191-22-021814 · doc4.xml · nonDerivative · entry 1

Adams Brian · CIK 0001636994 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,584

F1 · shares: Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 992 shares of restricted stock units ("RSUs") on March 26, 2022. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.

F2 · balance_after: Includes 51,173 shares underlying RSUs.

Read SEC document
March 29, 2022 Filed Mar 31, 2022 21:41 UTC
Bergstrom Donald APresident, R&D
SaleCommon Stock 622 $29.87 $18,579.14
Disclosure

SEC source: 0001209191-22-021820 · doc4.xml · nonDerivative · entry 1

Bergstrom Donald A · CIK 0001709772 · President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,304

F1 · shares: Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 2,187 shares of restricted stock units ("RSUs") on March 26, 2022. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.

F2 · balance_after: Includes 91,200 shares underlying RSUs.

Read SEC document
March 24, 2022 Filed Mar 29, 2022 00:18 UTC
Catinazzo ThomasChief Financial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 13,286 $0.00 Strike: $4.12 $0.00
Disclosure

SEC source: 0001209191-22-021390 · doc4.xml · derivative · entry 3

Catinazzo Thomas · CIK 0001818261 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,257

Underlying: Common Stock · 13,286 shares

Expires 2028-04-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2021.

F4 · derivative.exercise_date: Twenty-five percent (25%) of the shares underlying this option vested on April 9, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date.

Read SEC document
March 24, 2022 Filed Mar 29, 2022 00:18 UTC
Catinazzo ThomasChief Financial Officer
SaleCommon Stock 13,286 $30.00 $398,580.00
Disclosure

SEC source: 0001209191-22-021390 · doc4.xml · nonDerivative · entry 2

Catinazzo Thomas · CIK 0001818261 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,259

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2021.

F3 · price: This transaction was executed in multiple trades at prices ranging from $30.00 to $30.02. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F2 · balance_after: Includes 52,165 shares underlying RSUs.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.